Natera Financial Ratios
NASDAQ: NTRAHealth CareMedical SpecialitiesUSD
400.71+9.92 (+2.54%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Natera ratio analysis
Natera earned a net margin of -9.0% in FY 2025, up from -11.2% a year earlier. Return on equity reached -12.2%, meaning Natera generated -0.12 dollars of profit for every dollar of shareholders' equity. Debt-to-equity stood at 0.05 versus 0.07 the year before, and the current ratio was 3.39.
Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Natera financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Price / sales | 13.57 | 12.32 | 6.65 | 4.82 | 13.52 | 20.62 | 7.56 | 2.85 | 2.27 | 2.78 |
| Price / book | 18.27 | 17.49 | 9.41 | 5.60 | 12.95 | 16.58 | 8.20 | 22.81 | 18.86 | 4.21 |
| Gross margin | — | — | — | — | — | — | — | 38.6% | 35.8% | 38.0% |
| Operating margin | -13.4% | -13.1% | -41.2% | -66.0% | -74.8% | -55.3% | -38.5% | -44.5% | -64.2% | -46.6% |
| Net margin | -9.0% | -11.2% | -40.2% | -66.8% | -75.4% | -58.8% | -41.3% | -49.7% | -65.2% | -46.2% |
| Free cash flow margin | 4.7% | 4.1% | -26.4% | -58.4% | -60.2% | -51.7% | -22.6% | -28.9% | -51.1% | -44.8% |
| Return on equity (ROE) | -12.2% | -15.9% | -56.8% | -77.6% | -72.2% | -47.2% | -44.8% | -398.5% | -541.5% | -69.9% |
| Return on assets (ROA) | -8.7% | -11.5% | -30.2% | -39.3% | -38.1% | -24.6% | -21.4% | -47.8% | -64.1% | -47.6% |
| Debt / equity | 0.05 | 0.07 | 0.47 | 0.51 | 0.51 | 0.10 | 0.18 | 1.56 | 1.97 | 0.35 |
| Current ratio | 3.39 | 4.00 | 4.10 | 3.90 | 4.99 | 4.33 | 2.91 | 2.11 | 1.71 | 1.81 |
| Revenue growth | 35.9% | 56.7% | 32.0% | 31.1% | 60.0% | 29.3% | 17.3% | 22.1% | -2.8% | 14.0% |